Changing the model of care during the COVID-19 pandemic: Same-day discharge of patients undergoing elective invasive cardiac procedures in Hong Kong
Percutaneous coronary intervention (PCI) is recommended as the treatment-of-choice for patients with acute coronary syndrome and stable coronary artery disease with persistent symptoms despite optimal medical therapy.1 While coronary artery disease is a highly prevalent condition and the leading contributor to the global disease burden,2,3 PCI has become one of the most frequently performed medical procedures globally. Historically, overnight observation is the standard of care for patients who have undergone PCI, to observe and treat for potentially serious complications, such as stent thrombosis, myocardial ischemia, access site complications and bleeding.
Source: Heart and Lung - Category: Intensive Care Authors: Cecilia Miu-Ching CHAN, Michael Kang-Yin LEE, Alan Ka-Chun CHAN, Man Ling HUI, Polly Wai Chi LI Source Type: research
More News: Angioplasty | Bleeding | Cardiology | Coronary Angioplasty | COVID-19 | Heart | Hong Kong Health | Intensive Care | Pandemics | Percutaneous Coronary Intervention | Thrombosis